Israeli And American Companies Create Marijuana Inhaler For Sleep
Image by Nikki Casey
By Naomi Zeveloff March 20, 2017
Insomnia sufferers often swear by a puff of marijuana before bed. Now an Israeli company is helping to medicalize the practice with an inhaler that delivers a stable and controlled dose of a cannabis formula that lasts through the night.
i.can.sleep is a joint venture of iCAN:Israel-Cannabis, a group building out the medical marijuana industry in Israel and CannRx, a U.S. corporation that develops medical applications for cannabis.
The joint venture was announced at CannaTech, a conference on medical marijuana happening in Tel Aviv from March 20-22.
“You take a puff or two depending on the dosage and in ten minutes you will be drowsy enough to sleep,” said William Levine of CannRx.
Israel is poised to give final approval to medical marijuana exports in the coming months. According to Kaye, Israel could reap $1 billion in the next two years.
Contact Naomi Zeveloff at zeveloff@forward.com
I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.
Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.
At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.
Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.
Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly.
— Rachel Fishman Feddersen, Publisher and CEO
Join our mission to tell the Jewish story fully and fairly.
